Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Hum Exp Toxicol ; 32(11): 1126-36, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23424215

RESUMO

Caffeine and 1,3-dimethylamylamine (DMAA) are widely used alone and in combination with dietary supplements. No investigation has determined the safety profile of chronic intake of caffeine or DMAA, alone or in combination, within the same study design. A total of 50 young and healthy men completed 12 weeks of daily supplementation with either a placebo (n = 11), caffeine at 250 mg day(-1) (n = 14), DMAA at 50 mg day(-1) (n = 13), or caffeine at 250 mg day(-1) + DMAA at 50 mg day(-1) (n = 12). Before and after 6 and 12 weeks of supplementation, the following variables were measured: body mass/composition, resting respiratory rate, blood pressure, 12-lead electrocardiogram, urinalysis, complete blood count, metabolic panel, lipid panel, and oxidative stress, inflammatory, and cardiac biomarkers. No interaction effects were noted for any variable (p > 0.05), with little change occurring across time for subjects in any of the four conditions. With the exception of urinary pH (p = 0.05; Pre (6.5 ± 0.1) higher than week 6 (6.1 ± 0.1)) and blood CO2 (p = 0.02; week 12 (25.9 ± 0.3 mmol L(-1)) higher than week 6 (24.8 ± 0.3 mmol L(-1))), no time effect was noted for any other variable (p > 0.05). These data indicate that 12 weeks of daily supplementation with caffeine and DMAA, alone or in combination, does not result in a statistically significant change in any of the measured outcome variables.


Assuntos
Aminas/administração & dosagem , Cafeína/administração & dosagem , Estimulantes do Sistema Nervoso Central/administração & dosagem , Suplementos Nutricionais , Adulto , Interações Medicamentosas , Humanos , Masculino , Adulto Jovem
3.
J Vet Intern Med ; 22(1): 60-5, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18289290

RESUMO

BACKGROUND: Vaccination and importation of dogs and cats are prohibited in the Galapagos, resulting in a uniquely isolated population. The purpose of this study was to determine the prevalence of infectious diseases of dogs and cats that impact their health, could spill over to native wildlife, or sentinel diseases of concern to humans. HYPOTHESIS: The isolation of dogs and cats in the Galapagos protects them from diseases common in mainland populations. ANIMALS: Ninety-five dogs and 52 cats presented during a neutering campaign. METHODS: A prospective cross-sectional study was performed. Blood was collected for serological and DNA evaluation of a panel of infectious diseases. RESULTS: Antibodies against parvovirus (100%), parainfluenza virus (100%), adenovirus 1/2 (66-67%), and distemper virus (22%) were present in dogs. Dirofilaria immitis was also common in dogs (34%), with lower prevalences of Wolbachia pipiens (22%), Bartonella sp. (13%), Ehrlichia/Anaplasma spp. (1%), and Mycoplasma haemocanis (1%) observed. Antibodies against panleukopenia virus (67%), Toxoplasma gondii (63%), calicivirus (44%), and herpesvirus 1 (10%) were detected in cats. Feline leukemia virus antigen, feline immunodeficiency virus antibody, or coronavirus antibodies were not detected. Bartonella sp. (44%) infections were common in cats, but only one was infected with M. haemofelis. CONCLUSIONS AND CLINICAL IMPORTANCE: Despite their relative seclusion from the rest of the world, cats and dogs of Isabela were exposed to many pathogens found in mainland South America. Parasite prophylaxis, neutering, and strict enforcement of animal movement restrictions would control a majority of the diseases. In the absence of vaccination, a reservoir of susceptible animals remains vulnerable to new disease introductions.


Assuntos
Doenças do Gato/epidemiologia , Doenças Transmissíveis/veterinária , Doenças do Cão/epidemiologia , Animais , Gatos , Doenças Transmissíveis/epidemiologia , Estudos Transversais , Cães , Equador/epidemiologia , Doenças Endêmicas/veterinária , Feminino , Masculino , Prevalência , Estudos Prospectivos
4.
Plant Dis ; 85(5): 561, 2001 May.
Artigo em Inglês | MEDLINE | ID: mdl-30823148

RESUMO

The recent discovery of the soybean aphid, Aphis glycines Matsamura, in the North Central region of the United States is significant because it is the first time that a soybean-colonizing aphid has been detected in the New World. Although the aphid has the potential to cause physiological loss of up to 52% on soybeans (4), it can also transmit Soybean mosaic virus (SMV). Transmission of Alfalfa mosaic virus (AMV) has not been reported. SMV, and less commonly AMV, are found in soybeans in the North Central states and are transmitted by numerous aphids in a nonpersistent manner (2; Grau, unpublished). For SMV, potential exists for specificity of transmission between virus strain and aphid species (3). For these reasons, it was important to determine if an endemic isolate of these viruses could be transmitted by this introduced species of aphid in the North Central region. Transmission experiments were conducted as described (3), using 3, 5, and 10 aphids per plant. Ten plants of the soybean cultivar Williams 82 were used for each treatment. To preclude confounding results by possible seed transmission, plants used in all tests were grown from seeds harvested from virus-indexed plants grown in the greenhouse. For experiments involving SMV, the aphid-transmissible field isolate Al5 (GeneBank Accession no. AF242844) and, as a negative control, the non-aphid transmissible isolate N (GeneBank Accession no. D500507) were used. For experiments involving AMV, a field isolate of AMV, confirmed by ELISA and host range, was used. The aphid species Myzus persicae was maintained on broad bean and A. glycines was maintained on virus-free soybean. The protocol for transmission studies of AMV was identical to that used in the SMV study, except only A. glycines was tested. For experiments, plants were periodically observed for symptom development and tested by ELISA 4 to 5 weeks after inoculation access. No transmission of SMV-N occurred in any tests, which together involved 180 aphids each of M. persicae or A. glycines. For the Al5 isolate, transmission efficiencies of 30, 50, and 50% were obtained with 3, 5, and 10 individuals, respectively, of M. persicae per plant. Efficiencies for A. glycines were 30, 40, and 40%. Transmission levels by the two aphid species did not differ significantly (t-test, P = 0.01). For AMV, corresponding transmission efficiencies were 0, 0, and 20%. The data suggest that the introduced A. glycines can be an efficient vector of SMV, but a less efficient vector of AMV, in the North Central region. Transmission of AMV by M. persicae has been documented (1) but was not examined in this study. Transmission of SMV and AMV by A. glycines is of concern because it may increase SMV and AMV incidence. With the recent outbreak of Bean pod mottle virus (BPMV) in the region, the potential for synergism of SMV and BPMV is increased (2). References: (1) M. B. Castillo and G. G. Orlob. Phytopathology 56:1028, 1966. (2) G. L. Hartman et al., eds. 1999. Compendium of Soybean Diseases, 4th Ed. American Phytopathological Society, St. Paul, MN. (3) B. S. Lucas and J. H. Hill. Phytopathol. Z. 99:47, 1980. (4) C. L. Wang et al. Plant Prot. 20:12, 1994.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...